Virus Weekly articles from November 2002

Virus Weekly archives from November 2002

Graft T-cell depletion, alemtuzumab use linked to post-transplant adenovirus infection.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United Kingdom have elucidated the factors that can put stem cell recipients at risk for life-threatening adenovirus disease after...

Contact with children who may have chickenpox confers protection against shingles to adults.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Exposure to varicella-zoster virus by frequent contact with children appears to protect adults against herpes-zoster outbreaks, according to a report...

Regimen adherence for hepatitis C likely to result in better results.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Chronic hepatitis C patients, especially those infected with genotype 1, are more likely to see better results when they adhere to their prescribed treatment...

Specific effector activity reduces infection risk.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have confirmed that HIV-specific T-cell activity reduces the risk of infection after exposure to the virus. George Makedonas and...

Genetic findings in monkey herpes virus could aid research in human cancer.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- For the first time, scientists at the University of North Carolina (UNC) at Chapel Hill have discovered similar gene activity profiles between a herpes virus that affects rhesus macaque monkeys and a...

HPV16 antibodies cause regression of cervical neoplasia.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Neutralizing antibodies against human papillomavirus 16 (HPV16) appear to cause regression of cervical intraepithelial (CIN) lesions and may even...

Urine HIV-1 antibody test approved for life insurance screening.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corp. (CALY) , the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, announced that the West Virginia Office of the Insurance...

Autologous immunotherapy shown safe, effective.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- A clinical trial by researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) has shown a new autologous immunotherapy appears to be safe and effective treatment for controlling HIV....

Hepatitis C virus speeds progression in HIV patients on antiretrovirals.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The authors of an Italian study believe hepatitis C virus (HCV) coinfection in those infected with human immunodeficiency virus 1 (HIV-1) can speed up clinical...

Protease inhibitors compared in treatment-naive HIV/AIDS patients.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- A study presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego, California, showed that a regimen containing the investigational protease inhibitor...

Therapeutic interruptions not effective.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Structured therapeutic interruptions (STI), long hailed as a way of reducing the side effects of long-term AIDS treatment, has been shown to be ineffective, according to a collaborative study between...

U.S. patent granted covering key HIV target.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), announced the issue of a key U.S. patent in the area of HIV infection. The patent claims a specific GPCR sequence included in...

HIV fusion inhibitors featured at ICAAC.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Infectious disease specialists and scientists at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), heard new clinical data on a class of antiretrovirals that attacks HIV in a...

DNA/RNA testing systems manufacturer elects Cynthia L. Sullivan to board of directors.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Digene Corporation (NASDAQ:DIGE) announced that Cynthia L. Sullivan has been elected by the directors to serve on the Board of Directors of Digene. Sullivan is also a nominee for election as a director...

RIBA-3 HCV immunoassay best choice for blood product screening.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Australia have evaluated the performance of a pair of immunoblot screens for hepatitis C virus (HCV) contamination in donated blood. Philip...

Compounds selectively target zinc finger protein specific to HIV in vitro.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Achillion Pharmaceuticals announced the development of a new class of compounds that inhibits a broad spectrum of drug-resistant HIV strains by targeting a novel virus protein. ACH-0100703, a...

Expanding multiresistant HIV population in need of new classes of drugs.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., a leading research and advisory firm focusing on pharmaceutical and healthcare issues, announced that the expanding multiresistant HIV population is in need of new classes of...

Company receives FDA approval for Versant HIV bDNA viral load system.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Bayer Diagnostics announced that it received U.S. Food and Drug Administration approval for Versant HIV-1 RNA 3.0 Assay (bDNA), its nucleic acid probe diagnostic assay for the direct quantification of...

NIH intended for development of oral prophylactic/therapeutic HIV vaccine.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International (BDSI; BDSIW) announced that they have received a 2-year $600,000 National Institutes of Health (NIH) SBIR Grant to develop an oral form of a powerful HIV...

Emory microbiologists will study vaccines using NIH bioterrorism grant.(National Institutes of Health)(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Scientists at Emory University School of Medicine will study vaccines for viral hemorrhagic fevers, using a grant of more than $450,000 from the National Institutes of Health's Rapid Response Grants...

Data demonstrate potent antiviral activity of new anti-HBV agent.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- An L-nucleoside antiviral agent, administered orally once daily, rapidly produced potent antihepatitis B virus (HBV) activity in patients chronically infected with HBV, reported Beth Israel Deaconess...

Recombinant particles identify HCV antibody where standard assays fail.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists have developed recombinant hepatitis C virus (HCV)-like particles that allow for the identification of HCV antibody in patients who otherwise test...

FDA approves first 1-day, oral antiviral treatment of cold sores.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Valtrex (valacyclovir HCl) caplets for the treatment of cold sores...

Immunotherapeutic compound to be tested in animal model.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corporation (CVM) announced an agreement with the Cincinnati Children's Hospital Medical Center (CHMR) of the University of Cincinnati, Ohio, to evaluate Cel-Sci's new compound CEL-1000...

African Americans less likely than Caucasians to be vaccinated against flu.
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Fewer than half of African Americans over the age of 65 are vaccinated against influenza each year as compared with Caucasians, placing thousands of older African Americans at increased risk for...

Vaccine shipments should arrive in time for high-risk patients.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur, the largest U.S. supplier of influenza vaccine, planned to complete shipping partial orders of Fluzone, influenza virus vaccine, to all of its customers by the end of September, with...

Fears of an epidemic prompt urgent vaccination campaign in famine-hit Zimbabwe.(Brief Article)
November 5, 2002... 2002 NOV 5 - (NewsRx.com & NewsRx.net) -- Fears of a measles epidemic prompts urgent vaccination campaign in famine-hit Zimbabwe With an estimated 3 million Zimbabwean children at risk because of drought and food shortages, fears of a...

Woodchuck hepatitis virus replication diminishes in preneoplastic lesions.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Preneoplastic lesions in animals infected with a virus similar to hepatitis B virus (HBV) don't contain very many replicating virions, scientists have learned....

Interleukin-4 gene strongly affects respiratory syncytial virus disease severity.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and South Korea have identified a risk factor for abnormally dangerous respiratory syncytial virus infections. ...

Gene-attenuated viruses demonstrate anticancer effect.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Different combinations of E1B gene deletions can make genetically altered adenoviruses attractive candidates for cancer gene therapy. "For the aim of...

Novel noncytotoxic vaginal microbicide may help prevent HIV and other infections.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a promising microbicidal agent that may help prevent HIV and other sexually transmitted infections. ...

Urine test could make cervical cancer testing easier.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel urine screen for human papillomavirus (HPV) could make it easier to care for women infected with HIV, researchers in the United States say. "Human...

Fusion inhibitor granted priority review status by FDA.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris, Inc., (TRMS) announced that the U.S. Food and Drug Administration (FDA) has notified the companies that the New Drug Application (NDA) for Fuzeon (generic: enfuvirtide, formerly...

Pharmaceutical giant to let generic company manufacture its AIDS drug.(Boehringer Ingelheim)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Pharmaceutical company Boehringer Ingelheim is allowing a South African generic drug manufacturer produce and sell the crucial AIDS drug nevirapine. Boehringer Ingelheim, an American company based...

Oral medicines developer names expert in antiviral discovery and development as CEO.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Chimerix, Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, announced the appointment of George Painter, PhD, as company president and...

FDA approves Anti-R7V diagnostic kit as determinant for progression to AIDS.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- URRMA Biopharma, Inc., announced the U.S. Food and Drug Administration (FDA) has granted approval of URRMA's investigational device exemption (IDE) application for the Anti-R7V Diagnostic Kit. ...

RNA drug technology shows therapeutic promise against bioterror agents.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB), announced initial results of a new research collaborative agreement with the U.S. National Institutes of Health (NIH) designed to evaluate promising new experimental...

Therapeutic vaccine's safety shown in clinical evaluation.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- A clinical team in Mexico evaluating the AuRx therapeutic vaccine for genital herpes has published the initial results of a safety evaluation for the lowest dose in a phase I/II trial for treatment of...

Less expensive HIV progression test as effective as current tests in use.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Researchers at the Johns Hopkins Bloomberg School of Public Health and the University of Zurich, Switzerland, have identified a test for monitoring the progression of HIV in the early stages of the...

Potential new treatment described.(for hepatitis B)(Brief Article)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- Researchers from the Scripps Research Institute in La Jolla, California report that the compound interleukin-18 (IL-18) may control replication of the hepatitis B virus (HBV) and be an effective...

PEGylated Infergen to be developed for hepatitis C infection.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) and Inhale Therapeutic Systems, Inc., (INHL) announced an agreement for use of Inhale's technology to develop a PEGylated version of Infergen (Interferon alfacon-1)...

FluINsure vaccine results presented at ICAAC.(Interscience Conference on Antimicrobial Agents and Chemotherapy)
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that Dr. Scott Halperin of the Clinical Trials Research Center at IWK Health Center and Dalhousie University in Halifax, Nova Scotia, presented phase I clinical trial results...

Vaccination against and treatment for influenza appear to be cost-effective.
November 12, 2002... 2002 NOV 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A cost-benefit analysis conducted by a team at Duke University concluded vaccination against influenza and antiviral treatments for influenza-like...

Assay for hepatitis C core antigen suggests storage degrades viral components.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Evaluations of a new assay that can reveal hepatitis C virus (HCV) core antigen status suggest portions of the virus may degrade when held in long-term...

Respiratory syncytial virus genotype linked to disease severity.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the virus responsible for a number of childhood respiratory illnesses. "Respiratory syncytial...

Cold sore virus increasingly 'strongly associated' with early start to sex.(Brief Article)
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- Genital herpes due to HSV-1 - the herpes simplex virus primarily associated with cold sores on the mouth - is strongly associated with an early start to sex, suggests research in Sexually Transmitted...

Oral valganciclovir provides effective cytomegalovirus retinitis control.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel antiviral agent may make it easier to control cytomegalovirus (CMV) retinitis in AIDS patients, researchers say. Marisel Segarra-Newnham and...

Vaccination fails to protect French workers from the flu.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The 1996-1997 influenza vaccine (A/Wuhan/359/95 strain) was ineffective at protecting workers in France, according to a report in Occupational...

Drug discovery company names new chief financial officer.(Brief Article)
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) announced the promotion of Michael A. Darwin from controller to chief financial officer, treasurer and secretary, effective November 1, 2002. Mr....

CellExSys and Itochu partnership announced.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- CellExSys, Inc., a majority-owned subsidiary of Targeted Genetics Corp. (NASDAQ:TGEN) and Itochu Corp. announced they have agreed to form an alliance in the field of cellular therapy. Under the...

Human papillomavirus testing results predict cancer risk.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- Digene Corporation (NASDAQ:DIGE) announced that preliminary results from the University Hospitals of Reims and Besancon clinical trial in France demonstrate that the use of Digene's Hybrid Capture 2...

Valtrex evaluated in HIV-infected patients.(Brief Article)
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- Twice daily treatment with Valtrex (valacyclovir HCl) caplets is effective in suppressing genital herpes recurrences in HIV-infected patients, according to data presented at the Infectious Diseases...

Patients with myocarditis, hepatitis C virus, respond to immunosuppression.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Individuals affected by lone myocarditis may have concurrent hepatitis C virus (HCV) infection, according to an Italian study. Study authors say...

Hantavirus infection triggers long-term memory T-cell activity.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe have shed new light on the immune response to hantavirus infection. "Puumala virus (PUUV) is a hantavirus that...

FluINsure vaccine challenge study in U.K. is approved.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that it has received a favorable response from the Medicines Control Agency of the United Kingdom with regard to its application to conduct a phase II human "challenge" study...

Polyvalent sialic acid binding inhibitors show promise against some flu strains.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified an agent that shows promise as a treatment for severe cases of the flu. "Influenza A viral infection...

Review article covers details involved in developing effective influenza vaccines.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The effectiveness of an influenza vaccine prior to the season is difficult to predict because of uncertainty about circulating virus levels, vaccine...

"Switch" immunomodulator reverses cancerous cell properties in vitro.
November 19, 2002... 2002 NOV 19 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company's peptide nucleic-acid immunomodulator, Product R, induces differentiation of the human promyelocytic leukemia cell line HL-60 in cell...

Multiple characteristics of HAART affect adherence described.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- The total number of pills that need to be taken every day in HAART therapy has the greatest impact on adherence of 10 characteristics studied, according to a survey of HIV-positive individuals, nearly...

Glucosidase inhibitors could augment interferon in chronic hepatitis C.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists at Thomas Jefferson University say glucosidase inhibitors augment interferon in bovine viral diarrhea virus (BVDV). The Philadelphia,...

Myeloid-related proteins play key role in viral replication.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have identified a set of cellular proteins that appear to play a key role in the process of HIV replication. "S100A8, S100A9, and...

Cold sores likely caused by one of six genes.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Cold sores are the most common recurrent viral infection that people get, and University of Utah medical researchers say there's a good chance that a predisposition to them is inherited through one of...

Study: CAP nanoparticles induce immunity and protection from herpes.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced results of a study that found its patented calcium phosphate nanoparticles (CAP) vaccine adjuvant to be an effective mucosal adjuvant capable of...

Flu nipped in the bud at the Olympics.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- A system for early detection and treatment of upper respiratory infections at the 2002 Winter Olympics in Salt Lake City likely preserved some medals for at least one flu-ridden team. The system...

European marketing authorization sought for Fuzeon, an HIV fusion inhibitor.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris, Inc., (TRMS) announced the submission of a Marketing Authorization Application to the European Union (E.U.) for Fuzeon (enfuvirtide), formerly known as T-20, for HIV-1 infection in...

Antiretrovirus biotech firm names senior management team, scientific advisory board.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Mymetics Corp. (MYMX), an international biotechnology firm focused on molecular mimicry and retroviral diseases, announced the appointment of its senior management team and scientific advisory board....

Richard G. Babbitt named director and chairman of the board of delipidation company.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD) announced that Richard G. Babbitt has been elected to its board of directors and will serve as chairman. He will replace Christopher A. Marlett as chairman. Babbitt...

First platelet pathogen inactivation system receives CE clearance.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Subsidiaries of Baxter International Inc. (BAX), and Cerus Corporation (CERS) announced CE Mark declaration for the illuminator device for the Intercept Blood System. This represents the final...

Ultra-sensitive test detects hepatitis B virus mutants.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- IGEN International, Inc. (IGEN) announced that the Bloodborne Pathogens and Hepatitis Lab of Health Canada has developed an ultra-sensitive test for the detection of hepatitis B virus (HBV) mutants...

Grant awarded for evaluation of once-daily antiretroviral.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- The Bill & Melinda Gates Foundation announced that it has awarded Family Health International (FHI) a $6.5 million, 3-year grant for a multinational clinical trial to evaluate an antiretroviral...

Capsid protein tripeptides inhibit viral replication.
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Sweden have identified a series of molecules that could act as novel and potent anti-HIV agents. "Capsid assembly during virus replication...

Combination therapy effective for refractory hepatitis C infection.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- A study of a new combination therapy for patients with hepatitis C infection who had failed to respond to the drug ribavirin alone was presented at the American College of Gastroenterology's 67th...

Novel compound highly effective against cytomegalovirus infection.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Europe have identified a novel agent which could improve treatment of patients suffering from cytomegalovirus infections. "Human...

Patient randomization of Actimmune phase II trial completed.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- InterMune, Inc. (ITMN) announced that the company has completed patient randomization of its large phase II clinical trial of Actimmune (interferon gamma-1b) injection for the treatment of severe liver...

Better education can help doctors ease pain of shingles.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Primary care physicians say they would be more effective in treating the pain of postherpetic neuralgia (PHN) if they were better educated about the condition, according to survey results released at...

Detroit, Michigan-area hospitals collaborate on disaster preparedness drill.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- As part of ongoing emergency preparedness efforts throughout Detroit, Michigan, 11 area hospitals participated in a regional disaster preparation drill held in October 2002. Volunteers taking part...

Second vaccine study begins in Oakland, California.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- At the Oakland Medical Center, volunteer adults between 32 and 70 years old were revaccinated against smallpox in a study that will test the effectiveness of different dilutions of smallpox vaccine....

Onyx regains all rights to virus platform and initiates repartnering efforts.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Onyx Pharmaceuticals, Inc., (ONXX) announced that it has regained full rights to ONYX-015 having ended its agreement with Warner-Lambert Co., a subsidiary of Pfizer, Inc., (PFE) since June 2000. ...

Biotech company's portfolio expanded by 10 patents.(Brief Article)
November 26, 2002... 2002 NOV 26 - (NewsRx.com & NewsRx.net) -- Transgene (TRGNY) announced the expansion of protection of its vector technology portfolio with the issuance of 10 patents to date this year. Transgene was awarded six U.S. and four European...